Olivier Taelman

Directeur Général chez NYXOAH SA

Fortune : 4 M $ au 30/04/2024

54 ans

Health Technology

Consumer Services

Electronic Technology

Postes actifs de Olivier Taelman

Sociétés	Poste	Début	Fin
NYXOAH SA	Directeur/Membre du Conseil	01/09/2020	-
	Directeur Général	01/11/2019	-
	Directeur des opérations	01/07/2019	01/11/2019

Sociétés	Poste	Début	Fin
Autonomic Technologies, Inc. Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.	Corporate Officer/Principal	01/12/2015	01/11/2019
NEVRO CORP.	Corporate Officer/Principal	01/12/2013	01/12/2015

The Wharton School of the University of Pennsylvania	Masters Business Admin
Hasselt University	Undergraduate Degree

Internationale

Etats-Unis	4
Belgique	3

Opérationnelle

Corporate Officer/Principal	2
Director/Board Member	1
Chief Executive Officer	1

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	2
NYXOAH SA	Health Technology
NEVRO CORP.	Health Technology

Entreprise privées	1
Autonomic Technologies, Inc. Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA.	Electronic Technology

Entreprise privées

Electronic Technology